Business Description
Terumo Corp
ISIN : US88156J1051
Share Class Description:
TRUMY: ADRTotal Employee Number:
30,689Description
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.74 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 1.37 | |||||
Interest Coverage | 53.66 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.35 | |||||
Beneish M-Score | -2.5 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EBITDA Growth Rate | 14 | |||||
3-Year EPS without NRI Growth Rate | 15.7 | |||||
3-Year FCF Growth Rate | 42.5 | |||||
3-Year Book Growth Rate | 12.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 14.59 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.19 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.83 | |||||
9-Day RSI | 55.39 | |||||
14-Day RSI | 52.96 | |||||
3-1 Month Momentum % | 1.16 | |||||
6-1 Month Momentum % | 0.94 | |||||
12-1 Month Momentum % | -15.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.59 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.52 | |||||
Days Inventory | 214.76 | |||||
Days Sales Outstanding | 62.92 | |||||
Days Payable | 63.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.35 | |||||
Dividend Payout Ratio | 0.31 | |||||
3-Year Dividend Growth Rate | 14.5 | |||||
Forward Dividend Yield % | 1.35 | |||||
5-Year Yield-on-Cost % | 2.84 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | -1.48 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.54 | |||||
Operating Margin % | 15.58 | |||||
Net Margin % | 12.01 | |||||
EBITDA Margin % | 24.47 | |||||
FCF Margin % | 11.33 | |||||
OCF Margin % | 20.28 | |||||
ROE % | 9.33 | |||||
ROA % | 6.73 | |||||
ROIC % | 8.06 | |||||
3-Year ROIIC % | 7.23 | |||||
ROC (Joel Greenblatt) % | 23.49 | |||||
ROCE % | 11.07 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 24.61 | |||||
Forward PE Ratio | 20 | |||||
PE Ratio without NRI | 24.61 | |||||
Shiller PE Ratio | 33.81 | |||||
Price-to-Owner-Earnings | 24.51 | |||||
PEG Ratio | 1.88 | |||||
PS Ratio | 2.96 | |||||
PB Ratio | 2.11 | |||||
Price-to-Tangible-Book | 4.28 | |||||
Price-to-Free-Cash-Flow | 25.95 | |||||
Price-to-Operating-Cash-Flow | 14.49 | |||||
EV-to-EBIT | 18.97 | |||||
EV-to-Forward-EBIT | 18.48 | |||||
EV-to-EBITDA | 12.44 | |||||
EV-to-Forward-EBITDA | 13.01 | |||||
EV-to-Revenue | 3.04 | |||||
EV-to-Forward-Revenue | 3.45 | |||||
EV-to-FCF | 26.72 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Projected-FCF | 1.42 | |||||
Price-to-DCF (Earnings Based) | 1.27 | |||||
Price-to-DCF (FCF Based) | 1.26 | |||||
Price-to-Median-PS-Value | 0.73 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.56 | |||||
Price-to-Graham-Number | 2.16 | |||||
| Price-to-Net-Current-Asset-Value | 24.93 | |||||
Earnings Yield (Greenblatt) % | 5.27 | |||||
FCF Yield % | 3.85 | |||||
Forward Rate of Return (Yacktman) % | 18.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TRUMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Terumo Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 7,453.939 | ||
| EPS (TTM) ($) | 0.611 | ||
| Beta | 0.6481 | ||
| 3-Year Sharpe Ratio | -0.24 | ||
| 3-Year Sortino Ratio | -0.36 | ||
| Volatility % | 28.78 | ||
| 14-Day RSI | 52.96 | ||
| 14-Day ATR ($) | 0.334332 | ||
| 20-Day SMA ($) | 13.720775 | ||
| 12-1 Month Momentum % | -15.1 | ||
| 52-Week Range ($) | 12.08 - 19.6 | ||
| Shares Outstanding (Mil) | 1,475.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Terumo Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Terumo Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-12 | In 116 days | ||
| Second quarter earnings results for 2027 | 2026-11-12 | In 116 days | ||
| First quarter earnings conference call for 2027 | 2026-08-07 | In 19 days | ||
| First quarter earnings results for 2027 | 2026-08-07 | In 19 days | ||
| General meeting for 2026 | 2026-07-24 14:00 | In 6 days | ||
| Annual report for 2026 | 2026-06-23 | 13.89 (+0.07%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-15 | 12.18 (+0.00%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-15 | 12.18 (+0.00%) | ||
| USD 0.092656 Cash Dividend | 2026-03-31 | 13.14 (+1.08%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-13 | 13.34 (-4.71%) |
Show
Entries
Terumo Corp Frequently Asked Questions
What is Terumo Corp(TRUMY)'s stock price today?
The current price of TRUMY is $13.96. The 52 week high of TRUMY is $19.60 and 52 week low is $12.08.
When is next earnings date of Terumo Corp(TRUMY)?
The next earnings date of Terumo Corp(TRUMY) is 2026-08-07 Est..
Does Terumo Corp(TRUMY) pay dividends? If so, how much?
The Dividend Yield %  of Terumo Corp(TRUMY) is 1.35% (As of Today), Highest Dividend Payout Ratio of Terumo Corp(TRUMY) was 0.34. The lowest was 0.21. And the median was 0.29. The  Forward Dividend Yield % of Terumo Corp(TRUMY) is 1.35%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on OTCPK:TRUMY
No articles.
Press Release
Articles on Terumo Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers